[go: up one dir, main page]

WO2003018037A3 - Procede de regulation - Google Patents

Procede de regulation Download PDF

Info

Publication number
WO2003018037A3
WO2003018037A3 PCT/IB2002/003656 IB0203656W WO03018037A3 WO 2003018037 A3 WO2003018037 A3 WO 2003018037A3 IB 0203656 W IB0203656 W IB 0203656W WO 03018037 A3 WO03018037 A3 WO 03018037A3
Authority
WO
WIPO (PCT)
Prior art keywords
rate
regulating
growth
cell growth
relates
Prior art date
Application number
PCT/IB2002/003656
Other languages
English (en)
Other versions
WO2003018037A2 (fr
Inventor
Stephen Cohen
Aurelio Teleman
Original Assignee
European Molecular Biology Lab Embl
Stephen Cohen
Aurelio Teleman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119446.3A external-priority patent/GB0119446D0/en
Priority claimed from GBGB0124259.3A external-priority patent/GB0124259D0/en
Application filed by European Molecular Biology Lab Embl, Stephen Cohen, Aurelio Teleman filed Critical European Molecular Biology Lab Embl
Priority to AU2002330693A priority Critical patent/AU2002330693A1/en
Publication of WO2003018037A2 publication Critical patent/WO2003018037A2/fr
Publication of WO2003018037A3 publication Critical patent/WO2003018037A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des procédés de régulation du taux de croissance des cellules, des tissus et des organismes par la régulation du taux d'accumulation de masse cellulaire et du taux de progression des cycles cellulaires de manière coordonnée. En particulier, l'invention a trait à des procédés de régulation du taux de croissance des cellules, des tissus et des organismes par la modulation du niveau et de l'activité de protéines spécifiques. L'invention a trait également à l'utilisation desdites protéines, par exemple, dans le traitement de maladies et de conditions liées à un taux aberrant de croissance cellulaire.
PCT/IB2002/003656 2001-08-09 2002-08-08 Procede de regulation WO2003018037A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002330693A AU2002330693A1 (en) 2001-08-09 2002-08-08 Regulation method of cell growth

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0119446.3 2001-08-09
GBGB0119446.3A GB0119446D0 (en) 2001-08-09 2001-08-09 Binding proteins
GBGB0124259.3A GB0124259D0 (en) 2001-10-09 2001-10-09 Regulation method
GB0124259.3 2001-10-09

Publications (2)

Publication Number Publication Date
WO2003018037A2 WO2003018037A2 (fr) 2003-03-06
WO2003018037A3 true WO2003018037A3 (fr) 2003-10-02

Family

ID=26246421

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/003656 WO2003018037A2 (fr) 2001-08-09 2002-08-08 Procede de regulation

Country Status (2)

Country Link
AU (1) AU2002330693A1 (fr)
WO (1) WO2003018037A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1754487A1 (fr) * 2005-07-27 2007-02-21 The European Molecular Biology Laboratory Modulateurs de la protéine Melted et leur utilisation

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 January 1998 (1998-01-01), "Hypothetical 93.1 kDA protein", XP002235338, retrieved from EBI Database accession no. O17237 *
DATABASE EMBL [online] 1 May 2000 (2000-05-01), ADAMS M ET AL: "Melt protein", XP002235337, retrieved from EBI Database accession no. Q9VS24 *
DATABASE EMBL [online] 12 December 1999 (1999-12-12), PROKOPENKO S ET AL: "Drosophila melnogaster Melted (melt) mRNA, partial cds.", XP002235336, retrieved from EBI Database accession no. AF205831 *
DATABASE EMBL [online] 15 May 2001 (2001-05-15), ISOGAI T ET AL: "Homo sapiens cDNA FLJ14719 fis, clone NT2RP3001457, weakly similar to Drosophila melanogaster Melted mRNA", XP002235334, retrieved from EBI Database accession no. AK027625 *
DATABASE EMBL [online] 7 February 2001 (2001-02-07), OHARA O ET AL: "Homo sapiens mRNA for KIAA1692", XP002235333, retrieved from EBI Database accession no. AB051479 *
DATABASE EMBL [online] 7 February 2001 (2001-02-07), OTA T ET AL: "Human cDNA sequence SEQ ID No:11990", XP002235335, retrieved from EBI Database accession no. AAH14484 *
NAGASE T ET AL: "Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro", DNA RESEARCH, vol. 6, 1999, pages 337 - 345, XP000865804 *
PROKOPENKO S ET AL: "Mutations affecting the development of the peripheral nervous system in Drosophila: A molecular screen for novel proteins", GENETICS, vol. 156, December 2000 (2000-12-01), pages 1691 - 1715 *
STOCKER HUGO ET AL: "Genetic control of cell size.", CURRENT OPINION IN GENETICS & DEVELOPMENT, vol. 10, no. 5, October 2000 (2000-10-01), pages 529 - 535, XP002235332, ISSN: 0959-437X *

Also Published As

Publication number Publication date
WO2003018037A2 (fr) 2003-03-06
AU2002330693A1 (en) 2003-03-10

Similar Documents

Publication Publication Date Title
AU2003285172A1 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
WO2003072715A3 (fr) Proteine contenant un domaine de follistatine
MX219760B (en) Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
HUP0201973A3 (en) Isoxazolyl- and isoxazolinyl-substituted benzoylcyclohexanediones, production method and use thereof as herbicides and plant growth regulators
CY1117558T1 (el) Μεθοδος για καλλιεργεια κυτταρων για παραγωγη ουσιων
WO2003041496A1 (fr) Animal transgenique
WO2000078341A8 (fr) Methode de prophylaxie et/ou de traitement de troubles cliniques
WO2002083888A3 (fr) Utilisation de genes codant pour des pompes membranaires de transport afin de stimuler la production de metabolites secondaires dans des cellules biologiques
AU2003223608A1 (en) A method to increase the rate of cell growth
WO2004003152A3 (fr) Inhibiteurs de sos1
AU2001245319A1 (en) Methods of treating diseases with activated protein c
WO2003018037A3 (fr) Procede de regulation
AU2002315259A1 (en) A method for generating human nervous system cells, tissues, or neural stem cell progenitors from haematopoietic stem cells
IL137410A0 (en) A method for the production of transgenic plants using apical shoot tips
WO1997039107A3 (fr) Procede permettant d'accelerer la maturation des cellules
WO2003062197A3 (fr) Inhibiteurs de nek2
WO2004016749A3 (fr) Modulation antisens de l'expression de l'acyl-coa synthetase 1
WO2006013010A3 (fr) Preparation d'organismes a croissance plus rapide et/ou a meilleur rendement
AU2003268706A1 (en) PROCESS FOR PRODUCING OPTICALLY ACTIVE Alpha-SUBSTITUTED CYSTEINE OR SALT THEREOF, INTERMEDIATE THEREFOR, AND PROCESS FOR PRODUCING THE SAME
WO2003066852A3 (fr) Modulation de croissance des plantes
AU2001282194A1 (en) Biological control method against mosses, algae, fungi and other micro-organismsas well as the method to improve the growth of the plants
WO2002086130A3 (fr) Production de vegetaux a puroindolines genetiquement modifies
PL1687014T3 (pl) Zastosowanie dodatkowo przefermentowanego wywaru zbożowego do zapobiegania i/lub leczenia podwyższonych wartości cukru we krwi
WO2003018818A8 (fr) Procede et moyens de modulation des proteines du cycle cellulaire de plantes et leur utilisation pour reguler la croissance cellulaire de plantes
MXPA02010396A (es) Metodos para tratar plantas con acido glicolico.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP